Neurology
Two New Proteins Linked to ALS
Health
Summary: A new study identifies two proteins that interact with a mutant FUS variant linked to familial ALS, offering a potential therapeutic ...
Molecule Discovery Could Revolutionize Chronic Pain Treatment
Health
Summary: Researchers have identified a natural molecule, phosphatidic acid, that reduces the sensitivity of touch-sensing ion channels, providing a promising new avenue ...
Early Inflammation Linked to Midlife Cognitive Decline
Health
Summary: A new study finds that higher inflammation in young adulthood is associated with reduced cognitive function in midlife. Researchers discovered that ...
Breakthrough in Diagnosing Deadly Brain Disorder PSP
Health
Summary: Researchers identified protein biomarkers in spinal fluid that can diagnose progressive supranuclear palsy (PSP) in living patients. Using high-throughput technology, they ...
New Molecular Signatures Found for Alzheimer’s Disease
Health
Summary: Researchers identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer’s disease. They discovered altered communication between brain vascular cells mediated ...
Serotonin 2C Receptor Key to Memory
Health
Summary: Researchers discovered the serotonin 2C receptor in the brain plays a crucial role in regulating memory in both humans and animal ...
COVID-19 Vaccines May Reduce Virus-Induced Memory Problems
Health
Summary: COVID-19-induced cognitive impairment is linked to the protein IL-1β. Researchers found that vaccination can reduce brain inflammation and memory loss in ...
Key Brain Protein Reveals New Insights for Treating Neurological Disorders
Health
Summary: A novel study uncovers how the protein Gephyrin aids in synapse formation, providing new insights into brain connectivity. The findings could ...
Anxiety Doubles Parkinson’s Risk – Neuroscience News
Health
Summary: Researchers found that people over 50 with anxiety have twice the risk of developing Parkinson’s disease. Using UK primary care data ...
Ozempic May Reduce Alzheimer’s Risk
Health
Summary: GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 individuals for ...
